Prevalence of transfusion associated infections in multitransfused children in relation to mandatory screening of HIV in donated blood

Southeast Asian Journal of Tropical Medicine and Public Health

Volumn 28, Issue 4, 1997, Pages 699-706

  Aggarwal, Vyom ^a,c   Prakash, Charu ^b   Yadav, Sangeeta ^a   Chattopadhya, Debasish ^b  

^a MAULANA AZAD MEDICAL COLLEGE   (India)

^b NATIONAL INSTITUTE OF COMMUNICABLE DISEASES   (India)

^c BIRMINGHAM CHILDREN S HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; VIRUS ANTIGEN;

ADULT; ARTICLE; BLOOD; BLOOD DONOR; BLOOD TRANSFUSION; CHILD; COMPARATIVE STUDY; DISEASE TRANSMISSION; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INDIA; MALE; MANDATORY TESTING; PREVALENCE; VIRUS HEPATITIS;

ADULT; ANTIGENS, VIRAL; BIOLOGICAL MARKERS; BLOOD DONORS; BLOOD TRANSFUSION; CHILD; FEMALE; HEPATITIS, VIRAL, HUMAN; HIV INFECTIONS; HUMANS; INDIA; MALE; MANDATORY TESTING; PREVALENCE;

EID: 0031306416     PISSN: 01251562     EISSN: 26975718     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Aach RD, Kahn RA. Posttransfusion hepatitis; current perspective. Ann Intern Med 1980; 92 : 539-46.
2. Anonymous. HIV infection - ongoing studies and future research plans. Bull ICMR 1989; 19 : 115-29.
3. Centers for Disease Control. Inter-agency guidelines for screening donors of blood, plasma, organs, tissues, and semen for evidence of hepatitis B and hepatitis C. MMWR 1991; 40 : 1-17.
4. Chattopadhya D, Aggarwal R, Prakash C, Sen C, Kumari S. Sexually transmitted disease (STD) markers in multitransfused children in relation to human immunodeficiency virus Type-1 (HIV-I) infection: impact of STD markers in blood donors. J Trop Pediatr 1997; 43 : 178-81.
5. Chattopadhya D, Riley LW, Kumari S. Behavioural risk factors for acquisition of HIV infection and knowledge about AIDS among male professional blood donors in Delhi. Bull WHO 1991; 69 : 319-23.
6. th ed. New York: John Wiley and Sons, 1995.
7. Donahue JG, Munoz A, Ness PM. The declining risk of post-transfusion hepatitis C virus infection. N Engl J Med 1992; 327 : 369-73.
8. Ebeling F, Naukkarinen R, Leikola J. Post-tranfusion hepatitis C in Finland. Transf Med 1991; 1 : 109-13.
9. Gulati S, Marwaha RK,Dilawari JB, Midha U, Walia BNS. Serological responses to hepatitis B virus infection in multitransfused thalassemic children. Indian Pediatr 1992; 29 : 73-7.
10. Mattson L, Aberg B, Weilano O, Sellman M, Davilen J. Non-A, non-B hepatitis after open-heart surgery in Stockholm. Declining incidence after introduction of restrictions for blood donations due to human immunodeficiency virus. Scand J Infect Dis 1988; 20 : 374-6.
11. Menitove JE. The decreasing risk of tranfusion associated AIDS (Editorial). N Engl J Med 1989; 321 : 966-8.
12. Mirkovic R, Werch J, South MA, Benyesh-Melnick M. Incidence of cytomegalo-viraemia in blood donors and infants with congenital cytomegalic inclusion diseases. Infect Immun 1971; 3 : 45-50.
13. rd ed. Philadelphia: Lippincott-Raven, 1996; pp 173-218.
14. Neal KR, Jones DA, Killy D, James V. Risk factors for hepatitis C virus infection. A case control study of blood donors in the Trent region (UK). Epidemiol Infect 1994; 112 : 595-601.
15. Patawari SI, Irashad M, Gandhi BM. Post-transfusion hepatitis-A prospective study. Indian J Med Res 1986; 84: 508-10.
16. Quinn TC, Glasser D, Cannon RO. Human Immunodeficiency virus infection among patients attending clinics for sexually transmitted diseases. N Engl J Med 1988; 318 : 197-203.
17. Rosina F, Saracco G, Rizzetto M. Risk of post-transfusion infection with hepatitis delta virus. N Engl J Med 1985; 312: 1488-91.
18. Saran RK, Makroo RN. Transfusion medicine technical manual, DGHS Govt of India, 1991.
19. Simon TL, Bankhurst AD. A pilot study of surrogate tests to prevent transmission of acquired immunodeficiency syndrome by transfusion. Transfusion 1984; 24 : 373-8.
20. Smedile A, Dentico P, Zanelli P. Infection with delta agent in chronic HBsAg carriers. Gastroenterology 1981; 81 : 992-7.
21. Smedile A, Lavarini C, Farci P. Epidemiological patterns of infection with the hepatitis B virus-associated delta agent in Italy. Am J Epidemiol 1983; 117: 223-9.
22. Udani RH, Bharucha ZS, Pai PM. Post-transfusion hepatitis with reference to hepatitis-B antigenemia. Indian Pediatr 1986; 23 : 239-43.
23. Van der Poel CL. Hepatitis C virus: epidemiology, transmission and prevention. In: Reesink HW, ed. Hepatitis C virus. Curr Stud Hematol Blood Transf 1994; 61 : 137-63.
24. Weise W. Lesions from other infectious agents. In: Petrician JC, Gust ID, Weise W, eds, AIDS. The safety of blood and blood products. New York: John Wiley and Sons, 1987; 12 : 117-29.
25. Williams TN, Wonke, Donohue SM. A Study of hepatitis B and C prevalence and liver function in multiply transfused thalassemics and their parents. Indian Pediatr 1992; 29 : 119-24.
26. Yadav S, Chattopadhya D, Prakash C, Kumari S, Verghese T. Role of transfusion mediated viral infections on the lymphocyte profile in multitransfused children. J Trop Pediatr 1993; 39 : 243-50.
27. Yoshida Tachibana CFT, Nogueira Riberio RM, et al. Seroepidemiological survey of hepatitis A and B, cytomegalovirus and herpes simplex type-2 in blood donors from Rio de Janeiro, Brazil. Rev Microbiol 1987; 18: 5-11.
28. Zuckerman AJ, Thomas HC. Viral hepatitis, scientific basis and clinic management. New York: Churchill Libingstone 1993.